Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Risen (Suzhou) Pharma Tech Co., Ltd. v. Alzheon, Inc., No. 22-2232 (Fed. Cir. Mar. 11, 2024)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 22-2232
Decided
March 11, 2024
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit RISEN (SUZHOU) PHARMA TECH CO., LTD.,

Appellant

v.

ALZHEON, INC.,

Appellee

2022-2232

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2021-00347.

JUDGMENT

MARK YEH-KAI TUNG, Quinn Emanuel Urquhart & Sullivan, LLP, Redwood Shores, CA, argued for appellant. Also represented by JAMES M. GLASS, SEAN GLOTH, II, New York, NY. MARK J. FELDSTEIN, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for appellee. Also represented by DREW CHRISTIE, JOSHUA GOLDBERG, JESSICA L. ROBERTS, JASON LEE ROMRELL, YIEYIE YANG.

2THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

Figure on page 2 of the opinion

March 11, 2024

Date

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Risen (Suzhou) Pharma Tech Co., Ltd. v. Alzheon, Inc., No. 22-2232 (Fed. Cir. Mar. 11, 2024).

Record ID
CAFC-22-2232-20240311
Permalink
https://patentcasewatch.com/opinions/CAFC-22-2232-20240311

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.